Short Communications 23
Depression 6 - Preclinical (2)

Sun. May 26, 2024 10:45 AM - 11:45 AM Room 9 (G404)

Chair: Nasser Haddjeri (INSERM)

+Add all to schedule

[SC23-1] Psilocybin mitigates behavioral despair and cognitive recognition impairments by regulating the hypothalamic-pituitary-adrenal (HPA) axis via the brain-derived neurotrophic factor (BDNF) signaling pathway mediated by the endocannabinoid system (ECS).

*Zitong Wang¹, Yanbo Zhang¹, Xin-Min Li¹ (1. Department of Psychiatry, University of Alberta, Edmonton, Canada)

[SC23-2] Adiponectin elicits rapid-antidepressant effects in chronically stressed mice in association with increased glutamatergic activity in the mPFC

*Douglas Affonso Formolo¹, Tong Cheng¹, Suk-yu Yau¹ (1. Department of Rehabilitation Sciences, The Hong Kong Polytechnic University (PolyU), Hong Kong, China)

[SC23-3] Effects on the thalamus and insular cortex during vocal emotion processing by modafinil and bupropion: A pharmacological MRI study

*Michihiko Koeda^1,2, Tomoko Hama³, Yumiko Ikeda⁴, Hidenori Suzuki⁴, Yoshiro Okubo^2,5, Amane Tateno² (1. Department of Neuropsychiatry, Nippon Medical School Tama-Nagayama Hospital, 2. Department of Neuropsychiatry, Graduate school of medicine, Nippon Medical School, 3. Ehime Prefectural University of Health Science, 4. Department of Pharmacology, Graduate school of medicine, Nippon Medical School, 5. Tama-Chuou Hospital)

[SC23-4] The interplay between brain neurotransmitters and opioid systems in Major Depression (MD) and comorbid MD and Generalized Anxiety.

*Irina N Trofimova¹ (1. McMaster University)

[SC23-5] Psychosocial and genomic drivers of mental well-being in university students: novel findings from a world-first longitudinal study

*Divya Mehta Mehta¹, Shruthi M Suresh¹, Jessica Ann May Adams¹, Mackenzie Ashley Victor Rubens¹, Charlotte Bainomugisa¹, Dagmar Bruenig¹, Patricia Obst¹ (1. Queensland University of Technology)

Session information

Short Communications 23
Depression 6 - Preclinical (2)

[SC23-1] Psilocybin mitigates behavioral despair and cognitive recognition impairments by regulating the hypothalamic-pituitary-adrenal (HPA) axis via the brain-derived neurotrophic factor (BDNF) signaling pathway mediated by the endocannabinoid system (ECS).

[SC23-2] Adiponectin elicits rapid-antidepressant effects in chronically stressed mice in association with increased glutamatergic activity in the mPFC

[SC23-3] Effects on the thalamus and insular cortex during vocal emotion processing by modafinil and bupropion: A pharmacological MRI study

[SC23-4] The interplay between brain neurotransmitters and opioid systems in Major Depression (MD) and comorbid MD and Generalized Anxiety.

[SC23-5] Psychosocial and genomic drivers of mental well-being in university students: novel findings from a world-first longitudinal study

Authentication

Session information

Short Communications 23Depression 6 - Preclinical (2)

[SC23-1] Psilocybin mitigates behavioral despair and cognitive recognition impairments by regulating the hypothalamic-pituitary-adrenal (HPA) axis via the brain-derived neurotrophic factor (BDNF) signaling pathway mediated by the endocannabinoid system (ECS).

[SC23-2] Adiponectin elicits rapid-antidepressant effects in chronically stressed mice in association with increased glutamatergic activity in the mPFC

[SC23-3] Effects on the thalamus and insular cortex during vocal emotion processing by modafinil and bupropion: A pharmacological MRI study

[SC23-4] The interplay between brain neurotransmitters and opioid systems in Major Depression (MD) and comorbid MD and Generalized Anxiety.

[SC23-5] Psychosocial and genomic drivers of mental well-being in university students: novel findings from a world-first longitudinal study

Authentication

Short Communications 23
Depression 6 - Preclinical (2)